These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23382657)

  • 21. [Ghostwriting].
    Haug C
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881
    [No Abstract]   [Full Text] [Related]  

  • 22. Conflicted medical journals and the failure of trust.
    Jureidini JN; McHenry LB
    Account Res; 2011 Jan; 18(1):45-54. PubMed ID: 21287414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Knowledge on feet of clay].
    Dahlqvist R
    Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
    [No Abstract]   [Full Text] [Related]  

  • 24. Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin.
    Vedula SS; Li T; Dickersin K
    PLoS Med; 2013; 10(1):e1001378. PubMed ID: 23382656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disclosing clinical trial results: publicity, significance and independence.
    Liao SM; Sheehan M; Clarke S
    Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
    [No Abstract]   [Full Text] [Related]  

  • 26. Compounding risks to patients: selective disclosure is not an option.
    McGoey L
    Am J Bioeth; 2009 Aug; 9(8):35-6. PubMed ID: 19998156
    [No Abstract]   [Full Text] [Related]  

  • 27. Integrity and Transparency in Reporting Clinical Trials.
    Proehl JA; Alexander S; Manton AP
    Adv Emerg Nurs J; 2017; 39(1):1-2. PubMed ID: 28141604
    [No Abstract]   [Full Text] [Related]  

  • 28. [The journals must honestly tell who is doing the job].
    Bergström R
    Lakartidningen; 2008 May 7-13; 105(19):1406-7. PubMed ID: 18574981
    [No Abstract]   [Full Text] [Related]  

  • 29. Conflict of interest, round 2.
    Freedman R; Lewis DA; Michels R; Pine DS; Schultz SK; Tamminga C; Patterson SL; McIntyre JS; Goldman HH; Yudofsky SC; Hales RE; Rapaport MH; Hales D; Krajeski J; Kupfer DJ; Badaracco MA; Scully JH
    Am J Psychiatry; 2006 Sep; 163(9):1481-3. PubMed ID: 16946167
    [No Abstract]   [Full Text] [Related]  

  • 30. Commentary: What's wrong with ghostwriting?
    Elliott C; Landa AS
    Bioethics; 2010 Jul; 24(6):284-6. PubMed ID: 20497172
    [No Abstract]   [Full Text] [Related]  

  • 31. Industry and the academy: conflicts of interest in contemporary health research.
    Downie J; Baird P; Thompson J
    Health Law J; 2002; 10():103-22. PubMed ID: 14748274
    [No Abstract]   [Full Text] [Related]  

  • 32. Disclosing conflicts of interest in biomedical research.
    Reilly PR
    J Periodontol; 2007 Aug; 78(8):1472-5. PubMed ID: 17668964
    [No Abstract]   [Full Text] [Related]  

  • 33. Response to "the corporate coauthor".
    Wager E; Jacobs A
    J Gen Intern Med; 2005 Jul; 20(7):672. PubMed ID: 16050869
    [No Abstract]   [Full Text] [Related]  

  • 34. Conflict of Interest and the CREATE-X Trial in the New England Journal of Medicine.
    Ozaki A
    Sci Eng Ethics; 2018 Dec; 24(6):1809-1811. PubMed ID: 28916944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.
    Mansi BA; Clark J; David FS; Gesell TM; Glasser S; Gonzalez J; Haller DG; Laine C; Miller CL; Mooney LA; Zecevic M
    Mayo Clin Proc; 2012 May; 87(5):424-9. PubMed ID: 22560521
    [No Abstract]   [Full Text] [Related]  

  • 36. The duty to register phase I trials.
    Saunders PT
    Am J Bioeth; 2009 Aug; 9(8):41-2. PubMed ID: 19998160
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials.
    Roehr B
    BMJ; 2012 May; 344():e3767. PubMed ID: 22641830
    [No Abstract]   [Full Text] [Related]  

  • 38. Beyond trial registration: a global trial bank for clinical trial reporting.
    Sim I; Detmer DE
    PLoS Med; 2005 Nov; 2(11):e365. PubMed ID: 16220999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflict of interest: will it ever end?
    Carney SL
    Intern Med J; 2012 Nov; 42(11):1255-6. PubMed ID: 23157520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In the dark: drug companies should be forced to publish all the results of clinical trials.
    Chalmers I
    New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.